Evidence mapPaperPMID 35893597Full record

ArticlePathophysiology : the official journal of the International Society for Pathophysiology2022

Long-Term Preoperative Atorvastatin or Rosuvastatin Use in Adult Patients before CABG Does Not Increase Incidence of Postoperative Acute Kidney Injury: A Propensity Score-Matched Analysis.

Vladimir Shvartz, Eleonora Khugaeva, Yuri Kryukov, Maria Sokolskaya, Artak Ispiryan, Elena Shvartz, Andrey Petrosyan, Elizaveta Dorokhina, Leo Bockeria, Olga Bockeria

Open access · goldAbstract read
In one paragraph

Article in Pathophysiology : the official journal of the International Society for Pathophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Vladimir ShvartzDepartment of Surgical Treatment for Interactive Pathology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.ORCID 0000-0002-8931-0376
Eleonora KhugaevaDepartment of Surgical Treatment for Interactive Pathology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Yuri KryukovDepartment of Cardiovascular Surgery, Arrhythmology and Clinical Electrophysiology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.ORCID 0000-0001-9497-1972
Maria SokolskayaDepartment of Surgical Treatment for Interactive Pathology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Artak IspiryanDepartment of Surgical Treatment for Interactive Pathology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Elena ShvartzNational Medical Research Center for Therapy and Preventive Medicine, 101990 Moscow, Russia.ORCID 0000-0002-8638-7327
Andrey PetrosyanDepartment of Surgical Treatment for Interactive Pathology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Elizaveta DorokhinaDepartment of Cardiovascular Surgery, Arrhythmology and Clinical Electrophysiology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.ORCID 0000-0002-7194-0003
Leo BockeriaDepartment of Surgical Treatment for Interactive Pathology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Olga BockeriaDepartment of Surgical Treatment for Interactive Pathology, Bakulev Scientific Center for Cardiovascular Surgery, 121552 Moscow, Russia.
Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences · RUNational Research Center for Preventive Medicine · RU

Funding

Russian Science Foundation 18-74-10064
6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is among the expected complications of cardiac surgery. Statins with pleiotropic anti-inflammatory and antioxidant effects may be effective in the prevention of AKI. However, the results of studies on the efficacy and safety of statins are varied and require further study.

methodsWe conducted a retrospective cohort study to evaluate long-term preoperative intake of atorvastatin and rosuvastatin on the incidence of AKI, based on the "Kidney Disease: Improving Global Outcomes" (KDIGO) criteria in the early postoperative period after coronary artery bypass graft surgery (CABG). We performed propensity score matching to compare the findings in our study groups. The incidence of AKI was assessed on day 2 and day 4 after the surgery.

resultsThe analysis included 958 patients after CABG. After 1:1 individual matching, based on propensity score, the incidence of AKI was comparable both on day 2 after the surgery (7.4%) between the atorvastatin group and rosuvastatin group (6.5%) (OR: 1.182; 95%Cl 0.411-3.397;

conclusionLong-term statin use before CABG did not increase the incidence of postoperative AKI. Further, we revealed no difference in the incidence of post-CABG AKI between the atorvastatin and rosuvastatin groups.

Indexed as

acute kidney injuryatorvastatincoronary artery bypass graftrosuvastatinstatins

Identifiers

PMID35893597
PMCPMC9326680
OpenAlexW4285095125

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.